side effects switching from semaglutide to tirzepatide vs. Semaglutide: What You Should Know Switching from Semaglutide to Tirzepatide:

Alo's Clinical Bottom Line GLP-1 medicines cause a mild reduction in absolute muscle mass as part of the overall weight loss process

Both Novo Nordisk (manufacturer of Wegovy and Ozempic ) and Eli Lilly (manufacturer of Zepbound and Mounjaro ) maintain active pregnancy exposure registries to track maternal and fetal outcomes

(vi) reduction of endoplasmic reticulum stress

Linda K

This expanded utility could further enhance their market potential, providing pharmaceutical companies with robust evidence to support the effectiveness and versatility of GLP-1 medications, justifying broader coverage and reimbursement by healthcare payers